Clinicopathological features of 94 resected cases of hepatocellular carcinoma (HCC) with chronic hepatitis (CH group) were retrospectively studied in comparison with those of 156 cases of HCC with cirrhosis (LC group).
There was no significant difference in the positive rates of serum hepatitis B surface antigen (HBsAg) and heptitis C antibody (HCVAb) between the two groups. The prevalenece of HBsAg-positive HCCs and HCVAb-positive HCCs were 18.0% and 62.5% in CH group, and 17.6% and 76.2% in LC group, retrospectively. In CH group, the average age of HBsAg-positive HCCs was significantly younger than that of HCVAb-positive HCCs. In the cases of small liver cancer, the incidence of well-differentiated type was significantly higher in LC group (74.5%) than in CH group (50.0%).
On the other hand, moderately and poorly differentiated types were more frequently observed in CH group (moderately differentiated type, 40.0%; poorly differentiated type, 10.0%) than in LC group (moderately differentiated type, 21.6%; poorly differentiated type, 3.8%).
CH group had higher incidence of tumor invasion into portal vein branches, intrahepatic metastasis and capsule invasion. The association of adenomatous hyperplasia and well-differentiated HCCs in the vicinity of the resected HCCs suggested of multicentric origin of HCC was not observed in CH group.
Conclusively, it is predicted that HCCs in CH group may dedifferentiate in the earlier stage than HCCs in LC group, and most of them may be unicentric origin. These findings suggest that HCCs with chronic hepatits seem to be biologically different from LC group, and many of them seem to be more aggressive.
View full abstract